New York State Common Retirement Fund lessened its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 15.6% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 202,630 shares of the company’s stock after selling 37,332 shares during the period. […]

New York State Common Retirement Fund boosted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,203,639 shares of the healthcare conglomerate’s stock after buying an additional 16,572 […]

New York State Common Retirement Fund reduced its position in shares of McDonald’s Corporation (NYSE:MCD – Free Report) by 1.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 929,474 shares of the fast-food giant’s stock after selling 16,650 shares during the quarter. New […]

New York State Common Retirement Fund increased its stake in Accenture PLC (NYSE:ACN – Free Report) by 2.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 793,792 shares of the information technology services provider’s stock after buying […]

New York State Common Retirement Fund lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,150,543 shares of the healthcare product maker’s stock after selling 18,885 shares during the quarter. New York […]

New York State Common Retirement Fund lessened its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,562,317 shares of the biopharmaceutical company’s stock after selling 15,100 […]